| [1] 袁祖荣, 张巨烈. 重症急性胰腺炎治疗的现状和展望[J]. 肝胆外科杂志, 1998, 48(6): 321-322. [2] 刘泽涛, 程绍云. 重症急性胰腺炎治疗方式探讨（附 21 例报告）[J]. 青岛医药卫生, 1998, 5(6): 15. [3] AHO H J, NE VALAINEN T J, INDBERG R L, et al. Experimental pancreatities in the rat of phospholipase A in sodium taurocholate-included acute hemorrhagic pancreatitis[J]. Scrand J Gastroenterol, 1980, 15(2): 1027-1028. [4] KLAR E, WERNER J. New pathophysiologic knowledge about acute panereatitis[J]. Chirurg, 2000, 71(3): 253-264. [5] RAU B, POCH B, GANSAUGE F, et al. Pathophysiologic role of oxygen free radicals in acute panereatitis: initiating event or mediator oftissure damage[J]. Ann Surg, 2000, 231(3): 352-360. [6] YOO B M, OH T Y, KIM Y B, et al. Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic panereatitis in mouse model[J]. Pancreatology, 2005, 5(2/3): 165-176. [7] FOITZIK T, EIBL G, BUHR H. Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-antibodies and a specific endothelin a receptor antagonist[J]. J Gastrintest Surg, 2000, 4(3): 240-247. [8] 毛恩强, 张圣道, 韩天权, 等. 坏死性急性胰腺炎的持续损害因子——胰腺缺血[J]. 中华外科杂志, 1997, 35(9): 150-152. [9] PLUSCZYK T, WESTERMANN S, BERSAL B, et al. Temporary pancreatic duct occlusion by ethibloc: cause of microcirculatory shutdown, acute inflammation, and pancrea[J]. World J Surg, 2001, 25(4): 432-437. [10] KINNALA P J, KUTTILA K T, GRONROOS J M, et al. Splanchnic and pancreat-ic tissue perfusion in experimental acute pancreatitis[J]. Scancl J Gas-troenterol, 2002, 37(7): 845-849. [11] TAUBER S, MENGER M D, LEHR H A. Microvascular in vivo assessment of reperfusion injury: significance of prostaglandin E(1) and I(2) in postisehemic “no-reflow” and “reflow-paradox” [J]. J Surg Res, 2004, 120(1): 1-11. [12] LIU L R, XIA S H. Role of platelet activating factor in pathogenesis of acute pancreatitis[J]. Worid J Gastroenterol, 2006, 12(4): 539-545. [13] HENDERSON J R, DANIEL P M, FRASER P A. The pancreas as a single organ: the influence of the endocrine upon exocrine part of gland[J]. Gut, 1982, 22(1): 158. [14] 孙家邦, 朱斌. 重症急性胰腺炎治疗之我见[J]. 临床外科杂志, 1995, 3(4): 170-171. [15] NORMAN J, FRANZ M, FINK G. Timing of tumor necrosis factor an-tagonism is critical in determining outcome in murine lethal acute pancreatitis[J]. Surgery, 1996, 120(3): 515-521. [16] OAKLEYF, AU S, MANN D A, et al. Nuclear factor-kappaBl(p50)limits the inflammatory and fibregenie responses to chronic injury[J]. Am J Pathol, 2005, 166(3): 695-708. [17] SATOH A, GUKOVSKAYA A S, EDDERKAOUL M, et al. Tumornecrosis factor-alpha mediates pancreatitis response in acinar cells via protein kinase C and proline-rich tyrosine kinase -2[J]. Gastroenterology, 2005, 129(2): 639-651. [18] XUE D B, ZHANG W H, YUN X G, et al. Regulating effects ofarsenic trioxide on cell death pathways and inflammatory reactions of pancreatic acinar cells in rats[J]. Chin Med J, 2007, 120(8): 690-695. [19] GULCUBUK A, ALNATMAZ K, SONMEZ K, et al. Effects ofcurcum on tumor necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis[J]. Vet Med A Physiol Pathol Clin Med, 2006, 53(1): 49-54. [20] TAKEYATNA Y. Significance of apoptosis cell death in systemic complications with acute severe pancreatitis[J]. Gastroenteml, 2005, 40(1): 1-10. [21] 杨志霞, 林谦, 马利. 丹参对心血管疾病药理作用的文献研究[J]. 世界中西医结合杂志, 2012, 7(2): 93-96. [22] 李湘平, 尹桃. 丹参多酚盐注射液治疗冠心病的疗效观察[J]. 中国现代医学杂志, 2010, 20(4): 619-621, 624. [23] 金惠铭, 王建枝. 病理生理学[M]. 6 版. 北京: 人民卫生出版社, 2004: 205-205. |
